Cost-effectiveness of novel relapsed-refractory multiple myeloma therapies in Norway: lenalidomide plus dexamethasone vs bortezomib.
| Image |  |
|---|---|
| Description | scientific article published on 5 September 2011 |
| Author/s |
author: Jörgen Möller |
| Publication date | September 5, 2011 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |